Document ID: chunk:federal_register_of_legislation:F2022C00588:front:0:p4
Version: federal_register_of_legislation:F2022C00588
Segment Type: other
Provision Reference: 
Character Range: 8293–11266

middle ear or inner ear of the affected side, before the clinical onset of sensorineural hearing loss;
(16)      having leprosy before the clinical onset of sensorineural hearing loss;
(17)      having Paget's disease of bone, affecting the petrous temporal bone or middle ear ossicles of the affected side, at the time of the clinical onset of sensorineural hearing loss;
(18)      having a disease from the specified list of autoimmune diseases at the time of the clinical onset of sensorineural hearing loss;
            Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(19)      having multiple sclerosis at the time of the clinical onset of sensorineural hearing loss;
(20)      having diabetes mellitus at the time of the clinical onset of sensorineural hearing loss;
(21)      having a disease from the specified list of haematological diseases at the time of the clinical onset of sensorineural hearing loss;
            Note: specified list of haematological diseases is defined in the Schedule 1 - Dictionary.
(22)      having a cerebrovascular accident within the three months before the clinical onset of sensorineural hearing loss;
(23)      having a lesion interrupting the supply of blood to the cochlea of the affected ear at the time of the clinical onset of sensorineural hearing loss;
Note: Examples of lesions interrupting the supply of blood to the cochlea include, but are not limited to, thrombosis, haemorrhage or vasospasm of the vertebro-basilar circulation, and intralabyrinthine haemorrhage or infarction.
(24)      having blunt trauma, penetrating trauma or surgery to the cochlea or auditory nerve of the affected side, within the five years before the clinical onset of sensorineural hearing loss;
Note: Examples of trauma include, but are not limited to, temporal bone fracture and basilar skull fracture.
(25)      having a benign or malignant neoplasm involving the affected auditory nerve or cochlea at the time of the clinical onset of sensorineural hearing loss;
(26)      undergoing a course of therapeutic radiation for cancer, where the affected cochlea or auditory nerve was in the field of radiation, before the clinical onset of sensorineural hearing loss;
(27)      inhaling, ingesting or having cutaneous contact with an agent from the specified list of chemical agents, for a cumulative period of at least 2 500 hours within a continuous period of five years, before the clinical onset of sensorineural hearing loss, and where that exposure has ceased, the clinical onset of sensorineural hearing loss has occurred within two years of cessation;
            Note: specified list of chemical agents is defined in the Schedule 1 - Dictionary.
(28)      smoking at least 20 pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of sensorineural hearing loss, and where smoking has ceased, the clinical onset of sensorineural hearing loss has